Levodopa is the most effective drug for the treatment of Parkinson's
disease (PD). After about 5
Survival of patients with lymphoproliferative
diseases increases.
For effective treatment we should
in patients with coronary heart
disease
(CHD) and myocardial infarction (MI) may predict higher mortality rate
neurodegenerative
diseases, including Parkinson’s and Alzheimer’s
diseases. In the last few years, a number
Isaeva, A,
Averyanov, S,
Iskhakov, I,
Galimov, S,
Galimova, E,
Kiniabaev, T (2021) diseases, as well as for finding the safest and most effective drugs with different mechanisms of action
not only in patients at risk (with a history of inflammatory periodontal
diseases), but also in other
Background objectives: Chronic obstructive pulmonary
disease (COPD) is a complex chronic
With the high morbidity and mortality rates, cardiovascular
diseases have become one of the most